Literature DB >> 10630404

SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.

S Tomic1, N Chughtai, S Ali.   

Abstract

Suppressors of cytokine signaling, SOCS-1, SOCS-2 and SOCS-3, are non-transmembrane proteins with Src-homology-2 (SH2) domain, involved in negative regulation of the Janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathway. Using transient overexpression system the role of SOCS proteins in regulating prolactin receptor intracellular mediators leading to gene activation was analyzed. Overexpression of SOCS-1 led to a significant reduction in PRLR-mediated tyrosyl phosphorylation of Jak2, PRLR, Stat5 and the cytoplasmic protein tyrosine phosphatase SHP2. Overexpression of SOCS-3 however, led to selective inhibition in PRLR-mediated tyrosyl phosphorylation of Jak2, the PRLR as well as SHP2. On the other hand, overexpression of SOCS-2 had no inhibitory effects on the tyrosyl phosphorylation status of the PRLR, Jak2, Stat5 or SHP2 in response to PRLR activation. Finally, the role of SOCS proteins in regulating the biological activity of the PRLR was investigated. Unlike SOCS-2, both SOCS-1 and SOCS-3 abolished the ability of the PRLR to induce beta-casein gene promoter activation. These results demonstrate that SOCS-1, SOCS-2 and SOCS-3 are differentially implicated in PRLR signaling to gene activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630404     DOI: 10.1016/s0303-7207(99)00180-x

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

1.  SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice.

Authors:  G J Lindeman; S Wittlin; H Lada; M J Naylor; M Santamaria; J G Zhang; R Starr; D J Hilton; W S Alexander; C J Ormandy; J Visvader
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.

Authors:  Guanghua Li; Jianbo Xu; Zhao Wang; Yujie Yuan; Yin Li; Shirong Cai; Yulong He
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-28       Impact factor: 4.553

4.  STAT 5a expression in various lesions of the breast.

Authors:  Gary L Bratthauer; Brian L Strauss; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2005-08-19       Impact factor: 4.064

5.  PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.

Authors:  Jing Tao; Peter Oladimeji; Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-06-30

6.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.

Authors:  D Lejeune; J B Demoulin; J C Renauld
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

Review 7.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

8.  Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.

Authors:  Masahiro Maruoka; Shin Kedashiro; Yuki Ueda; Kiyohito Mizutani; Yoshimi Takai
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

Review 9.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

10.  Heterogeneous inducible mammary-specific expression of Jab/SOCS1 in lactating transgenic mice is associated with no obvious phenotype, even at the cellular level.

Authors:  Barbara Petridou; Solange Soulier; Nathalie Besnard; Marthe Hudrisier; Catherine Hue-Beauvais; José Costa Da Silva; Jean Djiane; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2003-12       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.